Feng, Weiwei
Novartis (United States)
2 papers on CoChatORCID 0000-0002-2923-1713
Most cited papers
- Verified
Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia
Darkow, T., Henk, H. J., Thomas, S. K., Feng, W., Baladi, J.-F., Goldberg, G. A., Hatfield, A., & Cortes, J. (2007) · PharmacoEconomics
Medication Adherence and ComplianceChronic Myeloid Leukemia Treatments
Cited by 271
- Verified
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients
Wu, E. Q., Johnson, S., Beaulieu, N., Arana, M., Bollu, V., Guo, A., Coombs, J., Feng, W., & Cortes, J. (2010) · Current Medical Research and Opinion
Medication Adherence and ComplianceChronic Myeloid Leukemia Treatments
Cited by 126
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free